Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any craniosynostosis in which the cause of the disease is a mutation in the ERF gene.
Features include always present findings: Retrognathia; and very common findings: Sagittal craniosynostosis. 20 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 4 | Lambdoidal craniosynostosis, Sagittal craniosynostosis, Coronal craniosynostosis |
ERF encodes ETS2 repressor factor (548 aa). Potent transcriptional repressor that binds to the H1 element of the Ets2 promoter. May regulate other genes involved in cellular proliferation. Highest expression in Fallopian Tube (95.0 TPM) and Nerve Tibial (86.1 TPM).
Craniosynostosis 4 is caused by mutations in the ERF gene on chromosome 19.
The ERF protein participates in ERF inhibits ETS2 expression pathway.
ERF is classified as a druggable target (Transcription Factor category) with score 5.8.
Genetic testing for ERF is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature, 1 very common feature, 10 common features.
No clinical trials have been registered for craniosynostosis 4.
9 publications have been identified in PubMed for craniosynostosis 4. Research spans Case Report / Case Series (44%), Basic Science / Preclinical (33%), and Clinical Trial Publication (11%).
Onur H (2026). [PMID: 42084887](https://pubmed.ncbi.nlm.nih.gov/42084887/). *Turk Arch Pediatr*. [Basic Science / Preclinical]
Chaisrisawadisuk S (2026). [PMID: 41562473](https://pubmed.ncbi.nlm.nih.gov/41562473/). *J Craniofac Surg*. [Clinical Trial Publication]
Edoh E (2026). [PMID: 42059179](https://pubmed.ncbi.nlm.nih.gov/42059179/). *Genet Med*. [Gene Therapy / Novel Therapeutics]
Jumayeva G (2026). [PMID: 39967053](https://pubmed.ncbi.nlm.nih.gov/39967053/). *Cleft Palate Craniofac J*. [Case Report / Case Series]
Goto Y (2025). [PMID: 40307313](https://pubmed.ncbi.nlm.nih.gov/40307313/). *Sci Rep*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 2:44 AM UTC
Online Mendelian Inheritance in Man
2 |
Delayed speech and language development, Depressed nasal bridge |
Hormones | 1 | Ectopic posterior pituitary |
Eyes | 1 | Optic nerve hypoplasia |
Dentici ML (2024). [PMID: 38824261](https://pubmed.ncbi.nlm.nih.gov/38824261/). *Eur J Hum Genet*. [Basic Science / Preclinical]
Hirano Y (2024). [PMID: 38741564](https://pubmed.ncbi.nlm.nih.gov/38741564/). *Am J Med Genet A*. [Case Report / Case Series]
Ranganathan R (2024). [PMID: 39650298](https://pubmed.ncbi.nlm.nih.gov/39650298/). *Int J Clin Pediatr Dent*. [Case Report / Case Series]